Hyaluronic acid- b -polylactic acid polymersomes facilitate CD44-mediated delivery of doxorubicin to glioblastoma in vitro
Year: 2026
Type: article
Abstract: Hyaluronic acid- b -polylactic acid polymersomes encapsulate and deliver doxorubicin (DOX) to glioblastoma cells through the CD44 receptor. They degrade in an acidic tumor-mimetic environment to release DOX, causing cell death.
Source: RSC Pharmaceutics
DOI: 10.1039/d6pm00188b
Authors: Apoorvi Chaudhri(Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft), Molli Garifo(Conceptualization, Data curation, Formal analysis, Investigation, Validation, Writing – original draft), Pranavi Thatavarthi, Torrick Fletcher, Jessica Larsen(Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing)
Institution: Clemson University
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: diamond
Funders: National Science Foundation, American Cancer Society, U.S. Department of Education, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, Division of Materials Research, Division of Chemical, Bioengineering, Environmental, and Transport Systems
Awards: REU Site: Research Experience for Undergraduates in Advanced Material Sciences, G2040256052, The CD101 pathway promotes T cell dysfunction in cancer and its blockade represents a novel line of immunotherapy, G5715831254, G6671297155, G6711204355, South Carolina IDeA Networks of Biomedical Research Excellence (SC INBRE), CAREER: Diagnosing the Undiagnosable: Using Enzyme Upregulation to Probe Cellular Behavior in Neuropathic Lysosomal Storage Disease, G9000370427, Transporting Stable RNA Across the Blood-Brain Barrier for On-Demand Translation
OpenAlex ID: W7213094830
